KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$0.33.

  • Biogen's EPS (Basic) fell 11803.28% to -$0.33 in Q4 2025 from the same period last year, while for Dec 2025 it was $8.83, marking a year-over-year decrease of 2130.12%. This contributed to the annual value of $8.83 for FY2025, which is 2123.1% down from last year.
  • Biogen's EPS (Basic) amounted to -$0.33 in Q4 2025, which was down 11803.28% from $3.18 recorded in Q3 2025.
  • In the past 5 years, Biogen's EPS (Basic) registered a high of $7.86 during Q3 2022, and its lowest value of -$0.68 during Q4 2021.
  • In the last 5 years, Biogen's EPS (Basic) had a median value of $2.7 in 2021 and averaged $2.82.
  • Per our database at Business Quant, Biogen's EPS (Basic) crashed by 13102.0% in 2021 and then surged by 66808.51% in 2024.
  • Biogen's EPS (Basic) (Quarter) stood at -$0.68 in 2021, then soared by 664.03% to $3.85 in 2022, then crashed by 55.29% to $1.72 in 2023, then increased by 6.4% to $1.83 in 2024, then plummeted by 118.03% to -$0.33 in 2025.
  • Its last three reported values are -$0.33 in Q4 2025, $3.18 for Q3 2025, and $4.33 during Q2 2025.